Semaglutide effects on cardiovascular outcomes in people with overweight or obesity
Clinical Trial Grant
Administered By
Duke Molecular Physiology Institute
Awarded By
Novo Nordisk, Inc.
Start Date
March 22, 2019
End Date
December 31, 2024
Administered By
Duke Molecular Physiology Institute
Awarded By
Novo Nordisk, Inc.
Start Date
March 22, 2019
End Date
December 31, 2024